{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/73535-208#drug","name":"MONJUVI","alternateName":"Tafasitamab-cxix","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"73535-208"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"BLA761163"},{"@type":"PropertyValue","propertyID":"UNII","value":"QQA9MLH692"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"ec13ac6b-bfde-4e84-907a-83bd69584d95"}],"activeIngredient":"TAFASITAMAB","administrationRoute":["INTRAVENOUS"],"dosageForm":"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION","manufacturer":{"@type":"Organization","name":"Incyte Corporation"},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/BLA761163","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ec13ac6b-bfde-4e84-907a-83bd69584d95","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=73535-208"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-02T12:31:49.306Z"}}